0000000000020210

AUTHOR

Cristina Pérez Ruiz

showing 2 related works from this author

Single-Cell Characterization of the Multiple Myeloma (MM) Immune Microenvironment Identifies CD27-Negative T Cells As Potential Source of Tumor-React…

2019

Background: The broad use of immunomodulatory drugs (IMiDs) and the breakthrough of novel immunotherapies in MM, urge the optimization of immune monitoring to help tailoring treatment based on better prediction of patients' response according to their immune status. For example, current T cells immune monitoring is of limited value because the phenotype of tumor-reactive T cells is uncertain. Aims: To characterize the MM immune microenvironment at the single-cell level and to identify clinically relevant subsets for effective immune monitoring. Methods: We used a semi-automated pipeline to unveil full cellular diversity based on unbiased clustering, in a large flow cytometry dataset of 86 n…

Oncologymedicine.medical_specialtyImmune statusbusiness.industryT cellImmune microenvironmenteducationImmunologyTumor cellsCell BiologyHematologymedicine.diseaseBiochemistryTransplantationmedicine.anatomical_structureBiological significanceInternal medicinemedicinePotential sourcebusinesshealth care economics and organizationsMultiple myeloma
researchProduct

Longitudinal Immunogenomic Profiling of Tumor and Immune Cells for Minimally-Invasive Monitoring of Smoldering Multiple Myeloma (SMM): The Immunocell…

2020

Background: Although great strides were made in the management of MM, our best chances to eradicate this malignancy may lie in preventing its progression.Most current models to predict risk of transformation in SMM are commonly established at diagnosis and not reevaluated over time, because some parameters such as tumor burden or genetic abnormalities require invasive bone marrow (BM) aspirates. It could be hypothesized that periodic monitoring of tumor biomarkers is needed to improve risk-stratification of SMM patients, and so would be new minimally-invasive methods that can replace those performed in BM samples. Such methods should also monitor immune profiles, to identify patients with s…

business.industryeducationImmunologyCell BiologyHematologymedicine.diseaseBiochemistryImmune systemCancer researchMedicineProfiling (information science)businesshealth care economics and organizationsMultiple myelomaBlood
researchProduct